Akcea and Ionis Report Positive Phase 2 Results in Hypertriglyceridemia More than 90% of patients achieved serum triglycerides ? 150 mg/dL at the highest monthly dose. 3 MIN READ 01.22.2020
Roche Gets PRIME (PRIority MEdicines) Status for Huntington’s Disease Therapy The European Medicines Agency's PRIME status is analogous to the FDA's Breakthrough Therapy designation. 3 MIN READ 08.3.2018
Markets May Have Got the Latest Ionis Pharmaceuticals, GlaxoSmithKline News Wrong Here's why the recent decision by GSK to turn down Ionis' TTR drug may not be as bad as it seems. 4 MIN READ 08.11.2017
Ionis: Success in Antisense Technology IONS continues to execute at a high level. 3 MIN READ 06.22.2017
